Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
Immudex is a fast-growing biotech company providing solutions for T-cell immune monitoring within immunotherapy, transplantation, infectious disease, and autoimmunity. Based on our proprietary Dextramer® technology, we develop and market research reagents and diagnostic assays, enabling researchers, developers, and clinicians to measure disease-specific T-cell responses.
You will be part of the Marketing Team and be in close contact with our Sales Team. The position is based in Virum, Denmark.
Your primary responsibility will be supporting the Sales and Marketing Teams in the different daily tasks. In more detail, this will include
You are a recent marketing and communications graduate with a strong interest in digital marketing. Ideally, you have the following qualifications:
We are looking for a customer-driven person with good organizational skills. You will be part of an international team in a fast-growing company, and where the position and responsibilities can also grow and evolve over time.
Immudex offers a dynamic workplace in a fast-growing company. We have an informal work environment characterized by dedicated employees with a desire to make a difference.
We process applications continuously, which is why we encourage you to send your application and CV as soon as possible to email@example.com.
If you have any questions about the position, please contact Global Marketing Manager Gemma Figueras at +45 3145 3499.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex manufactures MHC Dextramer® for the detection of antigen-specific T cells. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Immudex' MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in-vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development and monitoring of CMV cellular immunity in transplant and other immune-deficient patients. In Europe, the CE marked Dextramer® CMV Kit is approved for in vitro diagnostic use for the quantification of CMV-specific T cells. USA FDA 510(k) clearance for the CMV kit was granted in March 2017. GMP Grade reagents are available.
Our state-of-the-art dCODE Dextramer® reagents enable massive multiplexing of antigen-specific T-cell detection. Detection of over 1000 CD8+ T-cell specificities from a single blood sample has been achieved.